How much funding has Shasqi raised?

Shasqi has raised $60.5M in total funding, most recently a Series B round.

Where is Shasqi headquartered?

Shasqi is headquartered in San Francisco, California, United States.

What industry is Shasqi in?

Shasqi operates in Biotech, Healthcare, Therapeutics.

Shasqi

Q: Who are Shasqi's investors?

Shasqi's investors include Y Combinator Continuity Fund, Juan Jaen, Bill Rieflin.

Targeting cancer with click chemistry

San Francisco, United States · Founded 2015 · $60.5M raised

Biotech

Healthcare

Therapeutics

YC W15

Headquarters: San Francisco, California
Employees: 11–50
Founded: 2015
Business Model: B2B

Website: shasqi.com
Total Funding: $60.5M
Last Round: $50.0M Series BNov 2021
Rounds: 3

About

Shasqi is a clinical-stage biotech using Nobel Prize-winning click chemistry to develop tumor-targeted cancer therapies. Its CAPAC platform uses pre-targeting to activate drugs selectively at the tumor, enabling higher doses with reduced systemic toxicity. The company has collaborations with Johnson & Johnson and NIH, and is advancing its lead asset SQ3370 through clinical trials.

Summary

Shasqi is a Biotech company based in San Francisco, United States, founded in 2015. It has raised $60.5M in total across 3 rounds, most recently a $50.0M Series B round in Nov 2021. Investors include Y Combinator Continuity Fund, Juan Jaen and Bill Rieflin.

LinkedIn X (Twitter)